University of Miami (014) — Miami, Florida

University of Miami (014) is a clinical research site located in Miami, Florida, United States 33136.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

University of Miami (014) has participated in 1 clinical trials.

Therapeutic areas: Early Parkinson Disease.

Sponsors: Neurogen Corporation.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Miami (014)?

University of Miami (014) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Miami (014) conducted?

University of Miami (014) has 1 clinical trials on record. Their work covers Early Parkinson Disease.

Is University of Miami (014) accredited by Crixeo Health?

University of Miami (014) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Miami (014)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.